DRAXXIN Injectable Solution

Description

DRAXXIN Injectable Solution

DRAXXIN Injectable Solution is now the first-line product-of-choice to treat BRD, offering both superior disease treatment as well as outstanding efficacy for the control of BRD in cattle at high risk of developing the disease.

A single, subcutaneous injection of 1.14 mL/100 lb. (2.5 mg/kg) of bodyweight delivers a full course of therapy, thereby minimizing labor and handling stress.

DRAXXIN Injectable Solution is a ready-to-use sterile parenteral preparation containing tulathromycin, a semi-synthetic macrolide antibiotic of the subclass; triamilide. Each mL of DRAXXIN contains 100 mg of tulathromycin as the free base in a 50% propylene glycol vehicle, monothioglycerol (5 mg/mL), with citric and hydrochloric acids added to adjust pH.

DRAXXIN Injectable Solution

100 mL vial treats 17–500 lb cattle or 8,770 lbs of cattle treated

  • Do not use in female dairy cattle 20 months of age or older.
  • Do not use in calves to be processed for veal. Effects on reproductive performance, pregnancy and lactation have not been determined.

Reviews

There are no reviews yet.

Be the first to review “DRAXXIN Injectable Solution”

Your email address will not be published. Required fields are marked *